Inflammatory activity stratification improves liver stiffness diagnosis of fibrosis in autoimmune hepatitis - Report - MDSpire

Inflammatory activity stratification improves liver stiffness diagnosis of fibrosis in autoimmune hepatitis

  • By

  • Yan Huang

  • Delin Liu

  • Yunjiang Li

  • Xu Zhang

  • Yu Tang

  • June 10, 2026

  • 0 min

Share

Clinical Report: Stratification of Inflammatory Activity Enhances Liver Stiffness Measurement Accuracy for Fibrosis Diagnosis in Autoimmune Hepatitis

Overview

This study investigates the impact of inflammatory activity stratification on the accuracy of liver stiffness measurement (LSM) for diagnosing hepatic fibrosis in autoimmune hepatitis (AIH) patients. The findings indicate that stratification significantly improves diagnostic performance, particularly in patients with severe inflammation.

Background

Autoimmune hepatitis (AIH) is characterized by chronic liver inflammation and can lead to significant fibrosis and cirrhosis if not managed properly. Accurate assessment of hepatic fibrosis is crucial for determining treatment strategies and monitoring disease progression. Traditional diagnostic methods, including liver biopsy, carry risks and may not always provide accurate staging, highlighting the need for improved non-invasive techniques like LSM.

Data Highlights

GroupAUCOptimal Cutoff (kPa)Sensitivity (%)Specificity (%)
Overall0.738.2--
G1–G20.857.8--
G3–G40.699.155.088.5
G3–G4 (corrected)0.85-86.769.2

Key Findings

  • The AUC for diagnosing S≥2 fibrosis was 0.73 in the overall cohort.
  • Stratification of inflammatory activity improved AUC to 0.85 in the G1–G2 group.
  • The optimal cutoff for the G1–G2 group was 7.8 kPa, while for the G3–G4 group it was 9.1 kPa.
  • After correction for inflammation, sensitivity increased from 55.0% to 86.7% in the G3–G4 group.
  • Specificity decreased from 88.5% to 69.2% after correction in the G3–G4 group.

Clinical Implications

The findings suggest that incorporating inflammatory activity stratification into LSM can enhance diagnostic accuracy for fibrosis in AIH patients. Clinicians should consider this approach to avoid misclassification of fibrosis stages, particularly in patients with severe inflammation.

Conclusion

Stratifying inflammatory activity significantly improves the diagnostic performance of LSM for fibrosis assessment in AIH patients. Further validation is necessary before clinical implementation of this correction model.

Related Resources & Content

  1. EASL Clinical Practice Guidelines, EASL, 2025 -- Management of Autoimmune Hepatitis
  2. Frontiers | Inflammatory Activity Stratification Improves Liver Stiffness Diagnosis of Fibrosis in Autoimmune Hepatitis, Frontiers, 2026 -- Study on LSM in AIH
  3. European Radiology, Validation of T1ρ Mapping Techniques for Evaluating Hepatic Fibrosis, 2025 -- Techniques for Chronic Liver Conditions
  4. The New Gastroenterologist — Addressing NAFLD: Strategies to Alleviate the Effects of Nonalcoholic Fatty Liver Disease
  5. Journal of Gastroenterology — Approaches for Diagnosing and Monitoring Nonalcoholic Fatty Liver Disease Using Invasive and Noninvasive Techniques
  6. Frontiers in Pediatrics — Liver stiffness measured by transient elastography is associated with hepatic Fibrosis in children with portal vein thrombosis: a retrospective cross-sectional study
  7. Addressing NAFLD: Strategies to Alleviate the Effects of Nonalcoholic Fatty Liver Disease
  8. Approaches for Diagnosing and Monitoring Nonalcoholic Fatty Liver Disease Using Invasive and Noninvasive Techniques
  9. EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
  10. Frontiers | Inflammatory Activity Stratification Improves Liver Stiffness Diagnosis of Fibrosis in Autoimmune Hepatitis
  11. Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis - PubMed

Original Source(s)

Related Content